ISRCTN85268059
Completed
Not Applicable
Opioids in the management of breathlessness in advanced heart failure
Hull and East Yorkshire Hospitals NHS Trust (UK)0 sites48 target enrollmentSeptember 4, 2007
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Chronic heart failure
- Sponsor
- Hull and East Yorkshire Hospitals NHS Trust (UK)
- Enrollment
- 48
- Status
- Completed
- Last Updated
- 11 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. New York Heart Association (NYHA) grade three to four chronic heart failure with systolic dysfunction on echocardiography
- •2\. Receiving optimal medical management (diuretics and Angiotensin Converting Enzymes \[ACE] inhibitors/angiotensin 2 antagonists) stable for the past month
- •3\. Aged 18 years and over
Exclusion Criteria
- •1\. Inadequate renal function (Glomerular Filtration Rate \[GFR] less than 30 ml/min on Cockroft/Gault formula)
- •2\. Morphine allergy
- •3\. Currently receiving opioid therapy
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Opioids in the management of breathlessness in chronic heart failurePatients known to the Academic Unit of Cardiology that have symptomatic chronic heart failure (New York Heart Association grading 3-4) despite maximal medical treatment.MedDRA version: 9.1Level: LLTClassification code 10008908Term: Chronic heart failureEUCTR2006-006718-13-GBHull and East Yorkshire NHS Trust48
Active, not recruiting
Phase 1
BONG: Breathlessness and alternatives to Opioid treatment in Non-malign Groups of severe lung diseaseEUCTR2022-004238-20-DKVejle Hospital30
Recruiting
Phase 1
Effect of a pain killer on breathing and another drug that stimulates breathingnone, healthy subjects onlyTherapeutic area: Phenomena and Processes [G] - Physiological processes [G07]Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03]CTIS2023-503912-34-00eiden University Medical Center18
Active, not recruiting
Phase 1
Palliation of Dyspnea and Cough using Morphine in patients with Fibrotic Interstitial Lung DiseaseFibrotic Interstitial Lung DiseaseMedDRA version: 21.1Level: PTClassification code: 10022611Term: Interstitial lung disease Class: 100000004855Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]CTIS2023-503700-81-00Aarhus University Hospital110
Completed
Not Applicable
PRediction of Opioid-induced respiratory Depression In patients monitored by capnoGraphY (PRODIGY)Patients monitored by capnoGraphYJPRN-UMIN000026993Covidien Japan Inc.1,650